1 |
33078873 |
10.1002/gcc.22901 |
2022 |
Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience. |
RUNX1 |
2 |
33368842 |
10.1002/gcc.22933 |
2022 |
Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia. |
RUNX1 |
3 |
33890726 |
10.1002/cjp2.211 |
2022 |
CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways. |
RUNX1 |
4 |
34250504 |
10.1158/2643-3230.BCD-20-0229 |
2022 |
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. |
RUNX1 |
5 |
34325057 |
10.1016/j.jmoldx.2021.07.008 |
2022 |
Comparison of Two Quantitative PCR-Based Assays for Detection of Minimal Residual Disease in B-Precursor Acute Lymphoblastic Leukemia Harboring Three Major Fusion Transcripts. |
RUNX1 |
6 |
34348305 |
10.1159/000518280 |
2022 |
Cytogenetic and Fluorescence in situ Hybridization Profile of Pediatric Acute Lymphoblastic Leukemia in a University Hospital in South India. |
RUNX1 |
7 |
34535762 |
10.1038/s41375-021-01409-9 |
2022 |
ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis. |
RUNX1 |
8 |
34547766 |
10.1182/bloodadvances.2021004895 |
2022 |
Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia. |
RUNX1 |
9 |
34597466 |
10.1002/pbc.29361 |
2022 |
Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse. |
RUNX1 |
10 |
34601571 |
10.1182/blood.2021013156 |
2022 |
Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2. |
RUNX1 |
11 |
34617433 |
10.4274/tjh.galenos.2021.2021.0326 |
2022 |
Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients |
RUNX1 |
12 |
34698360 |
10.3892/ijo.2021.5274 |
2022 |
lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis. |
RUNX1 |
13 |
34727170 |
10.1182/bloodadvances.2021005522 |
2022 |
Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia. |
RUNX1 |
14 |
34753926 |
10.1038/s41408-021-00570-9 |
2022 |
Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes. |
RUNX1 |
15 |
34788984 |
10.3324/haematol.2021.279177 |
2022 |
Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials. |
RUNX1 |
16 |
34819303 |
10.1101/mcs.a006157 |
2022 |
Hi-C detects genomic structural variants in peripheral blood of pediatric leukemia patients. |
RUNX1 |
17 |
34871373 |
10.1182/blood.2021012727 |
2022 |
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy. |
RUNX1 |
18 |
34902205 |
10.1111/cas.15239 |
2022 |
RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia. |
RUNX1 |
19 |
34933343 |
10.1182/bloodadvances.2021005634 |
2022 |
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001. |
RUNX1 |
20 |
34940123 |
10.3390/cimb43030149 |
2022 |
Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression. |
RUNX1 |
21 |
34974289 |
10.1016/j.cancergen.2021.12.003 |
2022 |
Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21. |
RUNX1 |
22 |
34975010 |
10.1016/j.clml.2021.11.013 |
2022 |
Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia. |
RUNX1 |
23 |
34981432 |
10.1007/s12185-021-03269-6 |
2022 |
Newly diagnosed ETV6-RUNX1-positive B-acute lymphoblastic leukemia localized to the left pelvic bone marrow. |
RUNX1 |
24 |
34982829 |
10.1182/bloodadvances.2021005703 |
2022 |
A somatic UBA2 variant preceded ETV6-RUNX1 in the concordant BCP-ALL of monozygotic twins. |
RUNX1 |
25 |
34998786 |
10.1016/j.clml.2021.12.008 |
2022 |
The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia. |
RUNX1 |
26 |
34999180 |
10.1016/j.gene.2021.146132 |
2022 |
Identification of diagnosis and prognosis gene markers in B-ALL with ETV6-RUNX1 fusion by integrated bioinformatics analysis. |
RUNX1 |
27 |
35004601 |
10.3389/fpubh.2021.805757 |
2022 |
Risk Factors for Childhood Leukemia: Radiation and Beyond. |
RUNX1 |
28 |
35074994 |
10.4103/IJPM.IJPM_1154_20 |
2022 |
Erythrophagocytosis in a patient with B-cell acute lymphoblastic leukemia with t(12;21) (p13.2; q22.1); ETV6-RUNX1: Case report and review of the literature. |
RUNX1 |
29 |
35084434 |
10.1001/jamaoncol.2021.6826 |
2022 |
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia. |
RUNX1 |
30 |
35114276 |
10.1016/j.gene.2022.146234 |
2022 |
Oncogenic Runx1-Myc axis in p53-deficient thymic lymphoma. |
RUNX1 |
31 |
35253299 |
10.1002/gcc.23036 |
2022 |
CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia. |
RUNX1 |
32 |
35255774 |
10.1080/15548627.2022.2048432 |
2022 |
TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss. |
RUNX1 |
33 |
35258855 |
10.1007/s12185-022-03315-x |
2022 |
JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia. |
RUNX1 |
34 |
35290157 |
10.1080/10428194.2022.2047673 |
2022 |
Significance of <i>RUNX1</i> mutation in <i>BCR-ABL1</i> positive acute myeloid leukemia - a diagnostic dilemma in a young woman with persistent bleeding. |
RUNX1 |
35 |
35294722 |
10.1007/s11864-022-00963-3 |
2022 |
In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia. |
RUNX1 |
36 |
35379077 |
10.1080/10428194.2022.2057488 |
2022 |
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. |
RUNX1 |
37 |
35380239 |
10.1007/s00277-022-04806-x |
2022 |
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation. |
RUNX1 |
38 |
35506873 |
10.1080/10428194.2022.2064991 |
2022 |
Apparent coexistence of <i>ETV6::RUNX1</i> and <i>KMT2A::MLLT3</i> fusions due to a nonproductive <i>KMT2A</i> rearrangement in B-ALL. |
RUNX1 |
39 |
35533071 |
10.1080/10428194.2022.2067997 |
2022 |
Familial platelet disorder due to germline exonic deletions in <i>RUNX1</i>: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium. |
RUNX1 |
40 |
35543621 |
10.1080/10428194.2022.2070913 |
2022 |
Predictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis. |
RUNX1 |
41 |
35562965 |
10.3390/ijms23094574 |
2022 |
Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia. |
RUNX1 |
42 |
35575404 |
10.1093/jnci/djac101 |
2022 |
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia. |
RUNX1 |
43 |
35644195 |
10.7499/j.issn.1008-8830.2111108 |
2022 |
[Clinical features and prognosis of childhood B-lineage acute lymphoblastic leukemia expressing the <i>PRAME</i> gene]. |
RUNX1 |
44 |
35685993 |
10.21147/j.issn.1000-9604.2022.02.03 |
2022 |
Genomic landscape of T-cell lymphoblastic lymphoma. |
RUNX1 |
45 |
35865523 |
10.3389/fimmu.2022.868053 |
2022 |
Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice. |
RUNX1 |
46 |
35995457 |
10.1080/10428194.2022.2113524 |
2022 |
Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients. |
RUNX1 |
47 |
36011285 |
10.3390/genes13081374 |
2022 |
Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction. |
RUNX1 |
48 |
36045062 |
10.3343/alm.2023.43.1.92 |
2022 |
First Case of <i>ETV6-RUNX1</i> Fusion in Adult <i>De Novo</i> Acute Myeloid Leukemia Detected Using Targeted RNA Sequencing. |
RUNX1 |
49 |
31385734 |
10.1080/10428194.2019.1648801 |
2021 |
Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited <i>RUNX1</i> mutations without a pre-existing platelet disorder. |
RUNX1 |
50 |
31524018 |
10.1080/10428194.2019.1660975 |
2021 |
Leukemic lineage switch in a t(8;22)(p11.2;q11.2)/<i>BCR-FGFR1</i>-rearranged myeloid/lymphoid neoplasm with <i>RUNX1</i> mutation - diagnostic pitfalls and clinical management including FGFR1 inhibitor pemigatinib. |
RUNX1 |
51 |
31704777 |
10.1136/jmedgenet-2019-106339 |
2021 |
Novel phenotypes observed in patients with <i>ETV6</i>-linked leukaemia/familial thrombocytopenia syndrome and a biallelic <i>ARID5B</i> risk allele as leukaemogenic cofactor. |
RUNX1 |
52 |
31894899 |
10.1002/cyto.b.21865 |
2021 |
CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases. |
RUNX1 |
53 |
31944572 |
10.1002/cyto.b.21866 |
2021 |
CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia. |
RUNX1 |
54 |
31952221 |
10.3390/cells9010215 |
2021 |
<i>ETV6</i>/<i>RUNX1</i> Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia. |
RUNX1 |
55 |
32013644 |
10.1080/10428194.2020.1719089 |
2021 |
Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes. |
RUNX1 |
56 |
32091281 |
10.1080/10428194.2020.1723016 |
2021 |
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated <i>RUNX1</i> versus acute myeloid leukemia with myelodysplasia-related changes with mutated <i>RUNX1</i>. |
RUNX1 |
57 |
32118299 |
10.1111/bjh.16523 |
2021 |
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche. |
RUNX1 |
58 |
32150610 |
10.1182/bloodadvances.2019001008 |
2021 |
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia. |
RUNX1 |
59 |
32276273 |
10.1182/blood.2019003312 |
2021 |
E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia. |
RUNX1 |
60 |
32368831 |
10.1002/gcc.22858 |
2021 |
Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16. |
RUNX1 |
61 |
32378810 |
10.1002/cam4.3099 |
2021 |
High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia. |
RUNX1 |
62 |
32397113 |
10.3390/ijms21093323 |
2021 |
Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes. |
RUNX1 |
63 |
32467145 |
10.3324/haematol.2020.247973 |
2021 |
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. |
RUNX1 |
64 |
32541834 |
10.1038/s41423-020-0429-4 |
2021 |
Pluripotent stem cell-derived CD19-CAR iT cells effectively eradicate B-cell lymphoma in vivo. |
RUNX1 |
65 |
32573712 |
10.1182/blood.2019004090 |
2021 |
Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL. |
RUNX1 |
66 |
32579960 |
10.1016/j.bcp.2020.114116 |
2021 |
Inhibition of RUNX1 promotes cisplatin-induced apoptosis in ovarian cancer cells. |
RUNX1 |
67 |
32614960 |
10.1182/blood.2020005879 |
2021 |
Oncogenesis by E2A-PBX1 in ALL: RUNX and more. |
RUNX1 |
68 |
32651109 |
10.1016/j.clml.2020.05.020 |
2021 |
Childhood Therapy-Related Acute Myeloid Leukemia with t(16;21)(q24;q22)/RUNX1-CBFA2T3 After a Primitive Neuroectodermal Tumor of the Chest Wall. |
RUNX1 |
69 |
32693409 |
10.1182/blood.2020006164 |
2021 |
Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia. |
RUNX1 |
70 |
32757686 |
10.1080/10428194.2020.1798951 |
2021 |
Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>. |
RUNX1 |
71 |
32812094 |
10.1007/s10561-020-09855-y |
2021 |
Screening for pre-leukemia TEL-AML1 chromosomal translocation in banked cord blood units: cord blood bank perspective. |
RUNX1 |
72 |
32836179 |
10.1016/j.anndiagpath.2020.151588 |
2021 |
Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literature. |
RUNX1 |
73 |
32868912 |
10.1038/s41423-020-00527-1 |
2021 |
Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution. |
RUNX1 |
74 |
32898863 |
10.1182/blood.2020005622 |
2021 |
Identification of functional cooperative mutations of GNAO1 in human acute lymphoblastic leukemia. |
RUNX1 |
75 |
32911536 |
10.1182/blood.2019004381 |
2021 |
An intact gut microbiome protects genetically predisposed mice against leukemia. |
RUNX1 |
76 |
32946981 |
10.1016/j.exphem.2020.09.184 |
2021 |
Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature. |
RUNX1 |
77 |
33038982 |
10.1016/j.beha.2020.101193 |
2021 |
Molecular markers in ALL: Clinical implications. |
RUNX1 |
78 |
33070555 |
10.4143/crt.2020.507 |
2021 |
Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia. |
RUNX1 |
79 |
33074527 |
10.1007/s11684-020-0759-8 |
2021 |
Precision medicine in acute lymphoblastic leukemia. |
RUNX1 |
80 |
33095873 |
10.1182/bloodadvances.2019001307 |
2021 |
Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia. |
RUNX1 |
81 |
33113607 |
10.3760/cma.j.issn.0253-2727.2020.09.008 |
2021 |
[Diagnosis of adult Philadelphia chromosome-like acute lymphoblastic leukemia by fluorescence in situ hybridization]. |
RUNX1 |
82 |
33161783 |
10.1080/10428194.2020.1832664 |
2021 |
Identification of two novel mutations in human acute myeloid leukemia cases. |
RUNX1 |
83 |
33164984 |
10.1172/JCI140797 |
2021 |
Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivo. |
RUNX1 |
84 |
33170547 |
10.1111/ijlh.13386 |
2021 |
The gene expression level of m6A catalytic enzymes is increased in ETV6/RUNX1-positive acute lymphoblastic leukemia. |
RUNX1 |
85 |
33225787 |
10.1080/10428194.2020.1849680 |
2021 |
AML1-ETO inhibits acute myeloid leukemia immune escape by CD48. |
RUNX1 |
86 |
33245684 |
10.2217/epi-2020-0152 |
2021 |
Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia. |
RUNX1 |
87 |
33327998 |
|
2021 |
[Clinical significance of minimal residual disease in B-lineage acute lymphoblastic leukemia pediatric patients with different fusion gene backgrounds]. |
RUNX1 |
88 |
33328584 |
10.1038/s41568-020-00315-z |
2021 |
Advances in germline predisposition to acute leukaemias and myeloid neoplasms. |
RUNX1 |
89 |
33333691 |
10.3760/cma.j.issn.0253-2727.2020.11.003 |
2021 |
[Efficacy and prognostic factors of the chemotherapy regimen of CCLG-ALL-2008 on pediatric acute lymphoblastic leukemia with ETV6-RUNX1 rearrangement]. |
RUNX1 |
90 |
33355873 |
10.32471/exp-oncology.2312-8852.vol-42-no-4.15275 |
2021 |
Woman with Turner syndrome and her child with acute leukemia (a case report). |
RUNX1 |
91 |
33386596 |
10.1007/s12185-020-03063-w |
2021 |
The role of minimal residual disease in specific subtypes of pediatric acute lymphoblastic leukemia. |
RUNX1 |
92 |
33400146 |
10.1007/s11684-020-0821-6 |
2021 |
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia. |
RUNX1 |
93 |
33554816 |
10.19746/j.cnki.issn.1009-2137.2021.01.028 |
2021 |
[Characteristic of 8p11 Myeloproliferative Syndrome with Rare Phenotype]. |
RUNX1 |
94 |
33563056 |
10.1080/10428194.2021.1881503 |
2021 |
Searching for germline mutations in the <i>RUNX1</i> gene among Polish patients with acute myeloid leukemia. |
RUNX1 |
95 |
33646306 |
10.1182/bloodadvances.2020001844 |
2021 |
Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia. |
RUNX1 |
96 |
33714976 |
10.1038/s41375-021-01209-1 |
2021 |
Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks. |
RUNX1 |
97 |
33725318 |
10.1007/s12185-021-03116-8 |
2021 |
Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008. |
RUNX1 |
98 |
33739852 |
10.1200/JCO.20.02370 |
2021 |
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331. |
RUNX1 |
99 |
33743795 |
10.1186/s13045-021-01051-z |
2021 |
Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia. |
RUNX1 |
100 |
33750258 |
10.1080/0284186X.2021.1900908 |
2021 |
Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on <i>BCR-ABL1</i>-like subtype. |
RUNX1 |